Cologne Cohort of Neutropenic Patients (CoCoNut)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1+
SponsorUniversity Hospital of Cologne
About this trial
The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
immunosuppressed patients
Disqualifiers
none
Trial population
All patients developing neutropenia after receiving chemotherapy for any kind of malignant disease, treated in the University Hospital of Cologne
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Antiinfectives
DrugTo analyze to efficacy of (novel) drug therapies
Treatment groups
100,000 Participants
are divided into 1 treatment groupGroup A: Antiinfectives1 intervention
Trial outcomes
Primary outcomes
1
Long-term survival of hematology and oncology patients following neutropenia
Time frame
2 years following last follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov